Respiratory syrup in pharma franchise in Uttar Pradesh

Respiratory syrup in PCD pharma franchise in Chandigarh

Respiratory syrup in top pharma company in Imphal

Respiratory syrup in pcd pharma supplier in Jaipur

Respiratory syrup in phama franchise company in india
Respiratory syrup in phama distributor in Punjab

Home/Products /levosalbutamol-1mg-5ml-ambroxol-30mg-5ml-guaifenesin-50mg-5ml

Cufstik LS Syrup

Composition : Levosalbutamol 1mg + Ambroxol 30mg + Guaifenesin 50mg Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 100 ml

Price : ₹140/-

Cufstik LS Syrup is a powerful triple-action formulation designed to provide effective relief from chest congestion, productive cough, and breathing difficulties associated with various respiratory conditions. It contains Levosalbutamol (1mg), Ambroxol (30mg), and Guaifenesin (50mg)—each playing a crucial role in improving respiratory comfort and enhancing airway clearance.

Levosalbutamol is a bronchodilator that relaxes the muscles of the airways, making breathing easier. It is particularly effective in relieving bronchospasm and wheezing associated with asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). As a more selective and safer isomer of salbutamol, it provides rapid relief from shortness of breath with minimal cardiovascular side effects.

Ambroxol is a mucolytic agent that helps break down thick and sticky mucus in the airways, facilitating its easy expulsion. By improving mucus clearance, it supports natural breathing and reduces the chances of secondary infections caused by mucus retention.

Guaifenesin is an expectorant that thins and loosens mucus in the lungs, windpipe, and throat. It promotes productive coughing, allowing for more efficient removal of phlegm, thereby reducing chest congestion and discomfort.

Cufstik LS Syrup is ideal for patients suffering from wet or chesty cough due to infections such as bronchitis, allergic airway disorders, or post-viral cough. Its synergistic action offers comprehensive relief by opening up airways, dissolving mucus, and helping expel it from the respiratory tract.

This syrup is especially suitable for adults and children (as per dosage guidance) and should be administered after meals for better efficacy and gastrointestinal tolerance. It is a well-tolerated and fast-acting solution for symptomatic relief, allowing patients to recover respiratory function quickly and resume daily activities with ease.

For best results, the medication should be taken regularly at the same time each day, along with proper hydration to support mucus clearance. Avoid simultaneous use of other cough suppressants without medical advice.

Read More

About the Product

Cufstik LS Syrup is a powerful triple-action formulation designed to provide effective relief from chest congestion, productive cough, and breathing difficulties associated with various respiratory conditions. It contains Levosalbutamol (1mg), Ambroxol (30mg), and Guaifenesin (50mg)—each playing a crucial role in improving respiratory comfort and enhancing airway clearance.

Levosalbutamol is a bronchodilator that relaxes the muscles of the airways, making breathing easier. It is particularly effective in relieving bronchospasm and wheezing associated with asthma, bronchitis, and chronic obstructive pulmonary disease (COPD). As a more selective and safer isomer of salbutamol, it provides rapid relief from shortness of breath with minimal cardiovascular side effects.

Ambroxol is a mucolytic agent that helps break down thick and sticky mucus in the airways, facilitating its easy expulsion. By improving mucus clearance, it supports natural breathing and reduces the chances of secondary infections caused by mucus retention.

Guaifenesin is an expectorant that thins and loosens mucus in the lungs, windpipe, and throat. It promotes productive coughing, allowing for more efficient removal of phlegm, thereby reducing chest congestion and discomfort.

Cufstik LS Syrup is ideal for patients suffering from wet or chesty cough due to infections such as bronchitis, allergic airway disorders, or post-viral cough. Its synergistic action offers comprehensive relief by opening up airways, dissolving mucus, and helping expel it from the respiratory tract.

This syrup is especially suitable for adults and children (as per dosage guidance) and should be administered after meals for better efficacy and gastrointestinal tolerance. It is a well-tolerated and fast-acting solution for symptomatic relief, allowing patients to recover respiratory function quickly and resume daily activities with ease.

For best results, the medication should be taken regularly at the same time each day, along with proper hydration to support mucus clearance. Avoid simultaneous use of other cough suppressants without medical advice.

Possible side effects include nausea, vomiting, headache, dry mouth, dizziness, or mild gastrointestinal discomfort.

Indicated for the treatment of productive cough, chest congestion, and bronchospasm in respiratory infections, bronchitis, and asthma.

Not recommended for patients with known hypersensitivity to any ingredients or those with severe heart conditions. Always use under medical supervision.

Store below 30°C, away from direct light and moisture. Keep the bottle tightly closed and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation